Supplemental Table 3 Two-Class Paired Significance Analysis of Microarrays Comparing Gene Expression Between Paired

Supplemental Table 3 Two-Class Paired Significance Analysis of Microarrays Comparing Gene Expression Between Paired

Supplemental Table 3 Two‐class paired Significance Analysis of Microarrays comparing gene expression between paired pre‐ and post‐transplant kidneys biopsies (N=8). Entrez Fold q‐value Probe Set ID Gene Symbol Unigene Name Score Gene ID Difference (%) Probe sets higher expressed in post‐transplant biopsies in paired analysis (N=1871) 218870_at 55843 ARHGAP15 Rho GTPase activating protein 15 7,01 3,99 0,00 205304_s_at 3764 KCNJ8 potassium inwardly‐rectifying channel, subfamily J, member 8 6,30 4,50 0,00 1563649_at ‐‐ ‐‐ ‐‐ 6,24 3,51 0,00 1567913_at 541466 CT45‐1 cancer/testis antigen CT45‐1 5,90 4,21 0,00 203932_at 3109 HLA‐DMB major histocompatibility complex, class II, DM beta 5,83 3,20 0,00 204606_at 6366 CCL21 chemokine (C‐C motif) ligand 21 5,82 10,42 0,00 205898_at 1524 CX3CR1 chemokine (C‐X3‐C motif) receptor 1 5,74 8,50 0,00 205303_at 3764 KCNJ8 potassium inwardly‐rectifying channel, subfamily J, member 8 5,68 6,87 0,00 226841_at 219972 MPEG1 macrophage expressed gene 1 5,59 3,76 0,00 203923_s_at 1536 CYBB cytochrome b‐245, beta polypeptide (chronic granulomatous disease) 5,58 4,70 0,00 210135_s_at 6474 SHOX2 short stature homeobox 2 5,53 5,58 0,00 1562642_at ‐‐ ‐‐ ‐‐ 5,42 5,03 0,00 242605_at 1634 DCN decorin 5,23 3,92 0,00 228750_at ‐‐ ‐‐ ‐‐ 5,21 7,22 0,00 collagen, type III, alpha 1 (Ehlers‐Danlos syndrome type IV, autosomal 201852_x_at 1281 COL3A1 dominant) 5,10 8,46 0,00 3493///3 IGHA1///IGHA immunoglobulin heavy constant alpha 1///immunoglobulin heavy 217022_s_at 494 2 constant alpha 2 (A2m marker) 5,07 9,53 0,00 1 202311_s_at 1277 COL1A1 collagen, type I, alpha 1 5,07 10,41 0,00 1559889_at 440686 HIST2H3PS2 histone cluster 2, H3, pseudogene 2 5,03 3,81 0,00 collagen, type III, alpha 1 (Ehlers‐Danlos syndrome type IV, autosomal 215076_s_at 1281 COL3A1 dominant) 4,99 9,46 0,00 34210_at 1043 CD52 CD52 molecule 4,96 13,53 0,00 1552701_a_a t 114769 COP1 caspase‐1 dominant‐negative inhibitor pseudo‐ICE 4,93 3,47 0,00 212865_s_at 7373 COL14A1 collagen, type XIV, alpha 1 (undulin) 4,90 8,32 0,00 226311_at 9509 ADAMTS2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 4,88 5,01 0,00 1556499_s_at 1277 COL1A1 collagen, type I, alpha 1 4,88 5,88 0,00 212067_s_at 715 C1R complement component 1, r subcomponent 4,87 2,94 0,00 204162_at 10403 NDC80 NDC80 homolog, kinetochore complex component (S. cerevisiae) 4,85 7,87 0,00 1558834_s_at 254268 C1orf62 chromosome 1 open reading frame 62 4,84 4,73 0,00 201645_at 3371 TNC tenascin C (hexabrachion) 4,83 5,13 0,00 208747_s_at 716 C1S complement component 1, s subcomponent 4,78 4,90 0,00 collagen, type III, alpha 1 (Ehlers‐Danlos syndrome type IV, autosomal 211161_s_at 1281 COL3A1 dominant) 4,76 4,28 0,00 204829_s_at 2350 FOLR2 folate receptor 2 (fetal) 4,75 3,29 0,00 216575_at ‐‐ ‐‐ ‐‐ 4,71 3,16 0,00 205987_at 911 CD1C CD1c molecule 4,69 4,58 0,00 1563074_at 255654 LOC255654 hypothetical protein LOC255654 4,58 5,36 0,27 1562111_at 9577 BRE brain and reproductive organ‐expressed (TNFRSF1A modulator) 4,58 5,22 0,27 242878_at ‐‐ ‐‐ ‐‐ 4,57 2,61 0,27 202404_s_at 1278 COL1A2 collagen, type I, alpha 2 4,55 11,25 0,27 205484_at 27240 SIT1 signaling threshold regulating transmembrane adaptor 1 4,53 14,50 0,27 206392_s_at 5918 RARRES1 retinoic acid receptor responder (tazarotene induced) 1 4,52 3,99 0,27 224964_s_at 54331 GNG2 guanine nucleotide binding protein (G protein), gamma 2 4,52 3,00 0,27 209869_at 150 ADRA2A adrenergic, alpha‐2A‐, receptor 4,51 9,88 0,27 2 202310_s_at 1277 COL1A1 collagen, type I, alpha 1 4,49 5,16 0,27 233633_at 79718 TBL1XR1 transducin (beta)‐like 1X‐linked receptor 1 4,49 3,35 0,27 solute carrier family 1 (glutamate/neutral amino acid transporter), 244377_at 6509 SLC1A4 member 4 4,48 3,08 0,27 1566161_at 4212 MEIS2 Meis homeobox 2 4,47 4,30 0,27 1561564_at ‐‐ ‐‐ ‐‐ 4,44 4,35 0,27 222838_at 57823 SLAMF7 SLAM family member 7 4,42 10,33 0,35 229391_s_at 441168 FAM26F family with sequence similarity 26, member F 4,40 9,62 0,35 238408_at 55074 OXR1 oxidation resistance 1 4,40 3,74 0,35 205859_at 9450 LY86 lymphocyte antigen 86 4,39 3,99 0,35 209708_at 26002 MOXD1 monooxygenase, DBH‐like 1 4,38 5,28 0,35 1561123_at 5396 PRRX1 paired related homeobox 1 4,37 9,47 0,35 222895_s_at 64919 BCL11B B‐cell CLL/lymphoma 11B (zinc finger protein) 4,37 3,82 0,35 210629_x_at 7940 LST1 leukocyte specific transcript 1 4,36 8,02 0,35 234248_at ‐‐ ‐‐ ‐‐ 4,36 3,80 0,35 217147_s_at 50852 TRAT1 T cell receptor associated transmembrane adaptor 1 4,36 6,96 0,35 228372_at 170371 C10orf128 chromosome 10 open reading frame 128 4,33 3,77 0,35 219519_s_at 6614 SIGLEC1 sialic acid binding Ig‐like lectin 1, sialoadhesin 4,32 4,50 0,35 1569755_at ‐‐ ‐‐ ‐‐ 4,32 3,88 0,35 219528_s_at 64919 BCL11B B‐cell CLL/lymphoma 11B (zinc finger protein) 4,32 8,63 0,35 238529_at 8370 HIST2H4A histone cluster 2, H4a 4,31 4,56 0,35 244125_at 403340 MGC70870 hypothetical LOC403340 4,30 5,95 0,35 232645_at 153684 LOC153684 hypothetical protein LOC153684 4,29 4,08 0,35 219815_at 79690 GAL3ST4 galactose‐3‐O‐sulfotransferase 4 4,28 4,99 0,35 204205_at 60489 APOBEC3G apolipoprotein B mRNA editing enzyme, catalytic polypeptide‐like 3G 4,28 3,44 0,35 221731_x_at 1462 VCAN versican 4,28 8,11 0,35 243819_at 54331 GNG2 guanine nucleotide binding protein (G protein), gamma 2 4,27 4,47 0,35 3 1555852_at ‐‐ ‐‐ ‐‐ 4,26 3,22 0,35 1556516_at ‐‐ ‐‐ ‐‐ 4,26 2,85 0,35 239963_at ‐‐ ‐‐ ‐‐ 4,26 2,80 0,35 205872_x_at 9659 PDE4DIP phosphodiesterase 4D interacting protein (myomegalin) 4,26 5,03 0,35 204620_s_at 1462 VCAN versican 4,24 5,17 0,35 211881_x_at 28831 IGLJ3 immunoglobulin lambda joining 3 4,23 4,58 0,35 220146_at 51284 TLR7 toll‐like receptor 7 4,23 7,80 0,35 240988_x_at ‐‐ ‐‐ ‐‐ 4,22 6,82 0,35 1561926_at ‐‐ ‐‐ ‐‐ 4,22 5,39 0,35 204661_at 1043 CD52 CD52 molecule 4,22 12,70 0,35 1559289_at ‐‐ ‐‐ ‐‐ 4,20 8,71 0,35 224418_x_at 5369 PMCHL1 pro‐melanin‐concentrating hormone‐like 1 4,18 2,93 0,35 proteasome (prosome, macropain) subunit, beta type, 9 (large 204279_at 5698 PSMB9 multifunctional peptidase 2) 4,18 4,56 0,35 202947_s_at 2995 GYPC glycophorin C (Gerbich blood group) 4,17 2,94 0,35 226789_at ‐‐ ‐‐ ‐‐ 4,17 2,42 0,35 1564391_at 5825 ABCD3 ATP‐binding cassette, sub‐family D (ALD), member 3 4,17 3,47 0,35 237117_at ‐‐ ‐‐ ‐‐ 4,17 4,17 0,35 244042_x_at ‐‐ ‐‐ ‐‐ 4,16 10,39 0,35 219666_at 64231 MS4A6A membrane‐spanning 4‐domains, subfamily A, member 6A 4,15 4,99 0,35 206960_at 2846 GPR23 G protein‐coupled receptor 23 4,15 3,64 0,35 244605_at 2043 EPHA4 EPH receptor A4 4,14 5,14 0,35 1559696_at ‐‐ ‐‐ ‐‐ 4,13 5,74 0,35 225655_at 29128 UHRF1 ubiquitin‐like, containing PHD and RING finger domains, 1 4,12 3,24 0,35 225897_at 4082 MARCKS myristoylated alanine‐rich protein kinase C substrate 4,11 2,62 0,52 216193_at 440366 LOC440366 hect domain and RLD 2 pseudogene 4,09 11,32 0,52 214181_x_at 7940 LST1 leukocyte specific transcript 1 4,09 3,84 0,52 1564259_at 9099 USP2 ubiquitin specific peptidase 2 4,08 2,66 0,52 4 240890_at ‐‐ ‐‐ ‐‐ 4,08 2,59 0,52 205943_at 6999 TDO2 tryptophan 2,3‐dioxygenase 4,07 4,92 0,52 229968_at ‐‐ ‐‐ ‐‐ 4,05 3,97 0,52 225975_at 54510 PCDH18 protocadherin 18 4,04 4,47 0,52 242232_at 149401 LOC149401 hypothetical protein LOC149401 4,04 4,34 0,52 202953_at 713 C1QB complement component 1, q subcomponent, B chain 4,04 8,66 0,52 201048_x_at 5870 RAB6A RAB6A, member RAS oncogene family 4,04 1,97 0,52 proteasome (prosome, macropain) subunit, beta type, 8 (large 209040_s_at 5696 PSMB8 multifunctional peptidase 7) 4,03 3,11 0,52 225016_at 147495 APCDD1 adenomatosis polyposis coli down‐regulated 1 4,03 4,13 0,52 241945_at ‐‐ ‐‐ ‐‐ 4,03 2,50 0,52 1559697_a_a t ‐‐ ‐‐ ‐‐ 4,03 3,16 0,52 234203_at 9215 LARGE like‐glycosyltransferase 4,02 5,60 0,52 223922_x_at 64231 MS4A6A membrane‐spanning 4‐domains, subfamily A, member 6A 4,01 4,79 0,52 1554899_s_at 2207 FCER1G Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide 4,01 4,95 0,52 234179_at 313 AOAH acyloxyacyl hydrolase (neutrophil) 4,00 3,96 0,52 208119_s_at 81931 ZNF93 zinc finger protein 93 3,99 9,45 0,52 441519// /441520/ RP13‐ //441521 36C9.3///CT45 ///54146 ‐4///RP13‐ cancer/testis antigen CT45‐3///cancer/testis antigen CT45‐ 5///5414 36C9.6///CT45 4///cancer/testis antigen CT45‐5///cancer/testis antigen CT45‐ 235700_at 66 ‐6///CT45‐1 6///cancer/testis antigen CT45‐1 3,99 6,70 0,52 208235_x_at 2579 GAGE7 G antigen 7 3,99 14,39 0,52 233861_at ‐‐ ‐‐ ‐‐ 3,98 5,52 0,52 205381_at 10234 LRRC17 leucine rich repeat containing 17 3,97 2,43 0,52 243986_at 144766 LOC144766 hypothetical protein LOC144766 3,97 4,47 0,52 222940_at 6783 SULT1E1 sulfotransferase family 1E, estrogen‐preferring, member 1 3,96 2,05 0,52 5 223280_x_at 64231 MS4A6A membrane‐spanning 4‐domains, subfamily A, member 6A 3,96 4,37 0,52 1562223_at ‐‐ ‐‐ ‐‐ 3,96 16,84 0,52 232458_at ‐‐ ‐‐ ‐‐ 3,95 3,29 0,52 228094_at 120425 AMICA1 adhesion molecule, interacts with CXADR antigen 1 3,95 11,70 0,52 1559170_at ‐‐ ‐‐ ‐‐ 3,95 4,14 0,52 233815_at 10003 NAALAD2 N‐acetylated alpha‐linked acidic dipeptidase 2 3,95 2,54 0,52 217478_s_at 3108 HLA‐DMA major histocompatibility complex, class II, DM alpha 3,95 2,56 0,52 244348_at ‐‐ ‐‐ ‐‐ 3,95 2,65 0,52 1562992_at 79846 FLJ21062 hypothetical protein FLJ21062 3,94 5,69 0,52 210176_at 7096 TLR1 toll‐like receptor 1 3,94 1,92 0,52 223930_at ‐‐ ‐‐ ‐‐ 3,93 6,70 0,52 224006_at ‐‐ ‐‐ ‐‐ 3,92 4,40 0,52 244061_at 55843 ARHGAP15 Rho GTPase activating protein 15 3,92 4,77 0,52 240734_at ‐‐ ‐‐ ‐‐ 3,91 7,33 0,52 242491_at ‐‐ ‐‐ ‐‐ 3,91 6,71 0,52 206497_at 55744 C7orf44 chromosome 7 open reading frame 44 3,91 4,59 0,52 1552908_at 148823 C1orf150 chromosome 1 open reading

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    176 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us